Add to ORKGOne of the major strengths of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) in breast cancer imaging is in the evaluation of patients who have suspected loco-regional recurrence or distant metastasis. In general, FDG-PET is more sensitive than conventional imaging for the detection of recurrent disease. Because of its ability to more accurately stage patients who have advanced breast cancer, FDG-PET has a significant impact on choice of treatment and management in this patient group
F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the ear...
AIM: The aim of this study was to evaluate the impact of PET/CT on clinical management in patients w...
F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the ear...
Fluorine-18 fluorodeonyglucose positron emission tomography( FDG-PET) was used to detect local recur...
Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological disease...
Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological disease...
OBJECTIVE: To evaluate retrospectively the impact of [(18)F] fluorodeoxyglucose positron emission to...
Background. Standard imaging techniques, including chest x-ray, ultrasonography, magnetic resonance ...
This study assessed the diagnostic accuracy of whole-body PET on a patient and lesion basis using 18...
18F-FDG PET in combination with conventional imaging modalities could help avoid unnecessary biopsy ...
BACKGROUND: The aim of this prospective study was to evaluate the role of fluorodeoxyglucose positro...
Breast cancer is the most common female malignancy in Western countries. The limitations of mammogra...
Early detection of recurrence is clinically important and can im-prove the prognosis and survival of...
Background. After initial treatment of breast cancer (BC), monitoring locoregional recurrence and di...
In stage III breast carcinoma, metastasized disease needs to be determined. In the past, conventiona...
F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the ear...
AIM: The aim of this study was to evaluate the impact of PET/CT on clinical management in patients w...
F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the ear...
Fluorine-18 fluorodeonyglucose positron emission tomography( FDG-PET) was used to detect local recur...
Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological disease...
Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological disease...
OBJECTIVE: To evaluate retrospectively the impact of [(18)F] fluorodeoxyglucose positron emission to...
Background. Standard imaging techniques, including chest x-ray, ultrasonography, magnetic resonance ...
This study assessed the diagnostic accuracy of whole-body PET on a patient and lesion basis using 18...
18F-FDG PET in combination with conventional imaging modalities could help avoid unnecessary biopsy ...
BACKGROUND: The aim of this prospective study was to evaluate the role of fluorodeoxyglucose positro...
Breast cancer is the most common female malignancy in Western countries. The limitations of mammogra...
Early detection of recurrence is clinically important and can im-prove the prognosis and survival of...
Background. After initial treatment of breast cancer (BC), monitoring locoregional recurrence and di...
In stage III breast carcinoma, metastasized disease needs to be determined. In the past, conventiona...
F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the ear...
AIM: The aim of this study was to evaluate the impact of PET/CT on clinical management in patients w...
F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the ear...